의료용 해동 시스템 시장 규모, 점유율, 동향 및 예측 : 제품 유형별, 검체 유형별, 최종사용자별, 지역별(2026-2034년)

The global medical thawing system market size was valued at USD 233.0 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 401.7 Million by 2034, exhibiting a CAGR of 6.05% during 2026-2034. North America currently dominates the market, holding a significant market share of over 47.3% in 2025. This region's dominance is driven by advanced healthcare infrastructure, technological innovations, and increasing adoption of biopharmaceutical solutions.

As the healthcare industry continues to move toward personalized medicine and innovative treatment modalities, there is a need for effective and reliable thawing systems. For instance, in August 2024, Cardinal Health recently launched an 8,000 sq. ft. Advanced Therapy Innovation Center in La Vergne, Tennessee, which features cryogenic storage and enhanced capabilities for cell and gene therapy commercialization and logistics, directly addressing the need for precise temperature control during thawing to maintain sample viability. These systems hold a critical position for keeping and processing biological samples including stem cells and tissue grafts, which have to be thawed at an accurately maintained temperature to preserve the samples' viability and functionalities. Moreover, the escalating trend of chronic diseases along with the increased rate of surgeries call for such technologies making these inevitable; therefore, massive investments are made by healthcare facilities and biopharmaceutical companies towards even more advanced thawing technologies.

The United States is increasingly playing a significant role in the medical thawing system market by providing state-of-the-art equipment and technology to healthcare facilities and laboratories. With growing demands for efficient and accurate thawing systems, US manufacturers are continuously innovating for the needs of the medical industry. US companies are dedicated to the provision of high-quality thawing systems with precise control and reliable performance for the safe and efficient thawing of biological samples and medical products. Furthermore, US businesses are at the forefront in the global medical thawing system market, providing solutions that enhance patient care and advance medical research through research and development. For example, as of August 2024, more than 114,000 people are on the U.S. national transplant waiting list, and nearly 6,000 of them die every year without receiving an organ, so there is a dire need for advanced medical technologies such as thawing systems since efficient thawing technologies can have a direct impact on the preservation and viability of transplant organs.

MEDICAL THAWING SYSTEM MARKET TRENDS:

Rising Demand in Biopharmaceutical and Regenerative Medicine Applications

The growing use of biopharmaceuticals and regenerative medicine is driving the demand for effective medical thawing solutions. These industries need to follow accurate thawing protocols in order to maintain the integrity and viability of biological samples such as cell therapies, stem cells, and gene therapy products. The growing number of patients with chronic diseases and viral and bacterial infections is one of the main drivers for the market. This is in line with the fact that the propensity to opt for organ transplants is increasing, the number of organ donors are also on the rise with a rising demand for transfusion of blood. The raising need for regenerative medicines has been fueling the desire to thaw stem cells, tissue and other biological samples safety and efficiently, which therefore leads to the growth in this market. The global regenerative medicine market size reached USD 26.7 Billion in 2024.

Expansion of Blood Banks and Cryopreservation Facilities

The global expansion of blood banks and cryopreservation facilities is significantly contributing to the growth of the medical thawing market. For instance, in September 2024, the San Diego Blood Bank and SeaWorld San Diego partnership resulted in 17,000 blood product donations from over 11,000 donors, saving 34,000 lives and boosting local health infrastructure. The rising demand for frozen blood products, including plasma and red blood cells, highlights the critical role of thawing systems in emergency and routine medical procedures. Furthermore, the growing focus on cryopreservation for organ transplants, fertility treatments, and stem cell banking underscores the need for reliable thawing solutions. The deployment of advanced thawing equipment in these facilities ensures the rapid and safe preparation of samples, aligning with healthcare industry standards and fueling market expansion.

Growing Need for Thawing Solutions Driven by an Aging Population

The aging population is emerging as a significant factor influencing the medical thawing market. The UN projects that the global population aged 65 and above will rise from 10% in 2022 to 16% by 2050, growing faster than those below that age. There is an increasing prevalence of age-related conditions, such as cardiovascular diseases, diabetes, and cancer, which require advanced medical treatments. These treatments often rely on biopharmaceuticals, cryopreserved blood products, and regenerative therapies, all of which necessitate precise and efficient thawing processes. Moreover, the demand for frozen plasma, stem cells, and organ preservation solutions is growing, driven by the need to support advanced therapies and surgical procedures for older patients. Medical thawing systems equipped with precise temperature controls and rapid processing capabilities are crucial for ensuring the integrity and efficacy of these treatments.

MEDICAL THAWING SYSTEM INDUSTRY SEGMENTATION:

Analysis by Product Type:

• Manual
• Automated

Manual stand as the largest component in 2025, holding around 56.5% of the medical thawing system market share. This dominance reflects the continued reliance on manual thawing systems due to their simplicity, cost-effectiveness, and widespread use in various healthcare and laboratory settings. Manual systems are particularly favored in smaller facilities and resource-constrained environments where advanced automated solutions may not be feasible. Their ability to provide precise control during thawing processes, combined with ease of operation and maintenance, makes them a practical choice for many applications. As the demand for blood products, cryopreserved samples, and biological therapies continues to grow, the manual component remains an integral part of the global thawing market landscape.

Analysis by Sample Type:

• Blood
  • Plasma
  • Stem Cells
  • Whole Blood
  • Platelets
• Embryo
• Ovum
• Semen

Blood leads the market with around 53.2% of market share in 2025. This dominance underlines how important blood products are in modern-day healthcare, where efficient thawing systems are necessary for preparing plasma, red cells, and other components of blood for emergency and routine medical use. The growing occurrence of chronic diseases, greater surgical procedures, and the necessity of transfusions in cases of trauma and critical care are major drivers of this requirement. Advances in blood storage and preservation also increase the need for effective thawing technologies in ensuring that these products are safe and effective. In turn, this growing dependency further cements the segment's role in facilitating life-saving medical therapies.

Analysis by End User:

• Blood Banks
• Hospitals
• Tissue Banks
• Pharmaceutical and Biotech Companies
• Others

Blood Banks leads the market with around 31.7% of market share in 2025. This leadership reflects the critical role blood banks play in the healthcare ecosystem, where efficient thawing systems are essential for preparing blood products such as plasma and red blood cells for emergency and routine medical procedures. The growing prevalence of chronic conditions and the increasing frequency of surgeries and trauma cases have amplified the demand for thawed blood products. Additionally, advancements in blood preservation techniques and the expansion of blood bank networks globally have driven the adoption of advanced thawing systems. These systems ensure rapid, precise, and safe thawing, aligning with healthcare standards and supporting the seamless delivery of life-saving treatments.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2025, North America accounted for the largest market share of over 47.3%. This dominance is attributed to the region's advanced healthcare infrastructure, widespread adoption of innovative medical technologies, and significant investment in biopharmaceutical research. The growing prevalence of chronic diseases, coupled with the rising demand for cell and gene therapies, has further fueled the need for efficient medical thawing systems. Additionally, the expansion of blood banks, cryopreservation facilities, and regenerative medicine practices has amplified the demand for precise and reliable thawing equipment. North America's focus on stringent healthcare standards and regulatory compliance continues to drive innovation and market growth, solidifying its position as a global leader in this sector.

KEY REGIONAL TAKEAWAYS:

UNITED STATES MEDICAL THAWING SYSTEM MARKET ANALYSIS

US accounts for 84.4% share of the market share in North America in 2025. The medical thawing market in the United States is primarily driven by the growing demand for advanced medical treatments, such as stem cell therapies, organ transplantation, and fertility treatments, all of which require precise thawing of biological samples. According to the Organ Procurement and Transplantation Network (OPTN), a total of 46,632 organ transplants were performed in 2023, from both living and deceased donors, highlighting the increasing need for effective organ preservation and thawing technologies. Additionally, the rapid growth in biotechnology and healthcare sectors, supported by innovations in cryopreservation techniques, is fueling the market. Technological advancements in thawing equipment, including automated systems that ensure uniform temperature control and reduce human error, are expected to drive adoption in hospitals and laboratories. The US government's support for medical research through grants and funding further boosts market growth. Moreover, the aging population in the US, which requires more organ transplants, contributes to the demand for effective thawing solutions. As healthcare providers seek to maintain the integrity of biological samples during thawing, the need for state-of-the-art systems to meet safety standards is growing, driving the expansion of the medical thawing market.

ASIA PACIFIC MEDICAL THAWING SYSTEM MARKET ANALYSIS

The medical thawing market in the Asia Pacific (APAC) region is experiencing growth driven by increasing healthcare investments and the rising prevalence of non-communicable diseases (NCDs). According to the World Health Organization, 55% of all deaths in South-East Asia are due to NCDs, equating to nearly 8 Million deaths annually. This escalating health burden is fueling the demand for advanced medical treatments, including organ transplants and stem cell therapies, which require effective thawing technologies. Additionally, the growing biotechnology and pharmaceutical industries, along with rising healthcare spending in countries like China, India, and Japan, further drive the adoption of thawing systems. The expanding number of fertility clinics and stem cell research centers is also contributing to market growth. As healthcare policies and infrastructure continue to improve, the demand for efficient, high-precision thawing solutions is expected to rise across the region.

EUROPE MEDICAL THAWING SYSTEM MARKET ANALYSIS

The medical thawing market in Europe is driven by the increasing demand for advanced medical treatments, particularly in fertility clinics, organ transplants, and regenerative medicine. With an aging population across European countries, the demand for organ transplants is on the rise, leading to a greater need for efficient thawing solutions to maintain the integrity of tissues and organs. According to Eurostat, as of January 1, 2023, the EU population was estimated at 448.8 Million, with over one-fifth (21.3%) aged 65 years and older, further contributing to the rising demand for organ transplants. Additionally, the growing number of stem cell research and cryopreservation services across Europe is fueling market growth. The regulatory frameworks set by authorities such as the European Medicines Agency (EMA) play a significant role in ensuring safe and standardized thawing practices, encouraging the use of advanced thawing equipment in medical facilities. Furthermore, significant investment in healthcare research, alongside the presence of well-established healthcare providers, supports the adoption of high-precision thawing systems. As the healthcare sector continues to evolve, the demand for medical thawing solutions in Europe is set to expand, driven by advancements in medical technologies and the increasing need for biologically preserved tissues.

LATIN AMERICA MEDICAL THAWING SYSTEM MARKET ANALYSIS

In Latin America, the medical thawing market is driven by increasing investments in healthcare infrastructure and advancements in biotechnology and medical research. According to PubMed Central, in Brazil alone, approximately 928,000 deaths annually are attributed to chronic diseases, creating a growing demand for treatments such as organ transplants and stem cell therapies, which require reliable thawing systems. The expanding number of fertility clinics and research centers further supports market growth. Additionally, rising healthcare expenditures and government initiatives to improve healthcare access are contributing to the market's expansion, fostering greater demand for medical thawing solutions in the region.

MIDDLE EAST AND AFRICA MEDICAL THAWING SYSTEM MARKET ANALYSIS

In the Middle East, the medical thawing market is driven by the increasing prevalence of chronic diseases and a growing demand for advanced treatments such as organ transplants and fertility therapies. In the UAE, as part of its multi-year fiscal plan for 2022-2026, the government has allocated USD 1.56 Billion (AED 5.74 Billion) for healthcare and community prevention services, reflecting a 10.4% increase from the 2024 budget. This investment is expected to boost healthcare infrastructure and adoption of advanced medical thawing technologies. The region's growing focus on biotechnology and stem cell research further supports the market's expansion.

COMPETITIVE LANDSCAPE:

The market is characterized by intense competition among players striving to gain a larger medical thawing system market share. Major participants in the market are concentrating on product innovation, strategic partnerships, mergers and acquisitions, as well as expanding geographically to enhance their presence in the market. Market participants are also making considerable investments in research and development efforts to improve their product ranges and maintain a competitive edge. The competitive environment of the medical thawing system market is anticipated to become more intense as new companies enter with groundbreaking technologies. For instance, in March 2024, Biolife Solutions patented a method for consistent thawing of frozen samples in bag-format vessels, utilizing temperature measurement, qualified sensors, and multiple heater banks for accurate, efficient thawing.

The report provides a comprehensive analysis of the competitive landscape in the medical thawing system market with detailed profiles of all major companies, including:

• Barkey GmbH & Co. KG
• BioLife Solutions, Inc.
• Boekel Scientific
• Cardinal Health
• FreMon Scientific, Inc.
• Helmer Scientific Inc.
• KW Apparecchi Scientifici srl
• Labcold
• QED Scientific Ltd
• Sarstedt AG & Co. KG
• Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the medical thawing system market?

2. What is the future outlook of the medical thawing system market?

3. What are the key factors driving the medical thawing system market?

4. Which region accounts for the largest medical thawing system market share?

5. Which are the leading companies in the global medical thawing system market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Thawing System Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Manual
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Automated
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

• 7.1 Blood
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Plasma
    • 7.1.2.2 Stem Cells
    • 7.1.2.3 Whole Blood
    • 7.1.2.4 Platelets
  • 7.1.3 Market Forecast
• 7.2 Embryo
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ovum
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Semen
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Blood Banks
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Tissue Banks
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Pharmaceutical and Biotech Companies
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Barkey GmbH & Co. KG
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 BioLife Solutions, Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Boekel Scientific
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Cardinal Health
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 FreMon Scientific, Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Helmer Scientific Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 KW Apparecchi Scientifici srl
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Labcold
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 QED Scientific Ltd
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Sarstedt AG & Co. KG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Thermo Fisher Scientific Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis